Trial intelligence / Profile preview

Thymol-loaded chitosan gel for treatment of cutaneous leishmaniasis

IRCT20180526039848N1Phase 3Completed

Sponsor
Mashhad University of Medical Sciences
Start
Apr 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of thymol in cutaneous leishmaniasis (CL), sponsored by Mashhad University of Medical Sciences. Started Apr 2020; status: completed.

02

Drugs

thymol
03

Conditions

cutaneous leishmaniasis (CL)

Beyond the preview

Go deeper on IRCT20180526039848N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20180526039848N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call